Clinical Trial

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1 patients with multi-drug resistance.
Protocol Amendment History 85 amendments
This ClinicalTrials.gov record has been amended 85 times since 2015-02-12; most recent amendment 2026-05-26.
Status change: Recruiting → Active, Not Recruiting 2017-04-28
Status change: Not Yet Recruiting → Recruiting 2015-03-03
Trial Details
NCT Number NCT02362503
Lead Sponsor ViiV Healthcare
Conditions HIV Infections
Enrollment 371 participants
Start Date 2015-02-23
Primary Completion 2016-08-18 (estimated)
Study Completion 2027-01-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-17